Aker Christopher Ray

Track

Insider profile

Aker Christopher Ray's trades of Regulus Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-15 2025-01-14
PlS Planned sale
65,907 +5.1%
439.39
US$2,904,320 		65,907 +5.1% 439.39 US$2,904,320
2025-01-15 2025-01-13
PlS Planned sale
74,791 +36.9%
352.00
US$4,783,119 		74,791 +36.9% 352.00 US$4,783,119
2024-01-18 2024-01-18
PlS Planned sale
60,381 +8.0%
432.28
US$670,528 		60,381 +8.0% 432.28 US$670,528
2021-05-17 2021-05-17
PlS Planned sale
860 -2.0%
0.89
US$765 		860 -2.0% 0.89 US$765
2021-02-17 2021-02-16
PlS Planned sale
828 -1.9%
1.72
US$1,424 		828 -1.9% 1.72 US$1,424
2020-11-18 2020-11-16
PlS Planned sale
876 -3.3%
0.52
US$456 		876 -3.3% 0.52 US$456
2020-08-17 2020-08-14
PlS Planned sale
872 -3.2%
0.61
US$528 		872 -3.2% 0.61 US$528
2020-05-18 2020-05-15
PlS Planned sale
909 -3.2%
0.63
US$570 		909 -3.2% 0.63 US$570
2020-02-19 2020-02-18
PlS Planned sale
888 -3.0%
0.83
US$737 		888 -3.0% 0.83 US$737
2020-01-03 2020-01-02
PlS Planned sale
2,239 -7.1%
0.97
US$2,164 		2,239 -7.1% 0.97 US$2,164
2019-11-15 2019-11-14
PlS Planned sale
833 -2.6%
0.64
US$533 		833 -2.6% 0.64 US$533
2019-10-02 2019-10-01
PlS Planned sale
2,346 -6.8%
0.68
US$1,602 		2,346 -6.8% 0.68 US$1,602
2019-07-02 2019-07-01
PlS Planned sale
2,225 -5.9%
1.31
US$2,918 		2,225 -5.9% 1.31 US$2,918
2019-05-16 2019-05-15
PlS Planned sale
6,950 -10.5%
1.41
US$9,796 		6,950 -10.5% 1.41 US$9,796
2019-04-03 2019-04-01
PlS Planned sale
2,710 -30.1%
0.98
US$2,659 		2,710 -30.1% 0.98 US$2,659